Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Minarini

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry|February 6, 2007
Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moietiesVincenzo Tumiatti, Anna Minarini, Andrea Milelli, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2013
In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockersRyotaro Saiki, Yuki Yoshizawa, Anna Minarini, et al.
Amino Acids|August 23, 2011
Synthetic polyamines as potential amine oxidase inhibitors: a preliminary studyBonaiuto Emanuela, Anna Minarini, Vincenzo Tumiatti, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2018
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitorsAndrea Milelli, Chiara Marchetti, Eleonora Turrini, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 10, 2005
Heterocyclic inhibitors of AChE acylation and peripheral sitesMaria Laura Bolognesi, Vincenza Andrisano, Manuela Bartolini, et al.
Bioorganic & Medicinal Chemistry|July 4, 2008
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinicsAnna Minarini, Gabriella Marucci, Cristina Bellucci, et al.
ACS Chemical Neuroscience|April 20, 2017
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational ApproachElena Simoni, Melania M Serafini, Roberta Caporaso, et al.
Scientific Reports|September 10, 2016
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer's DiseaseAngelo M Reggiani, Elena Simoni, Roberta Caporaso, et al.
Journal of Medicinal Chemistry|October 31, 2003
Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptorsMichela Rosini, Alessandra Antonello, Andrea Cavalli, et al.
Molecules (Basel, Switzerland)|November 14, 2023
Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected TargetsFilippo Basagni, Maria Luisa Di Paolo, Giorgio Cozza, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|February 6, 2007
Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moietiesVincenzo Tumiatti, Anna Minarini, Andrea Milelli, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2013
In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockersRyotaro Saiki, Yuki Yoshizawa, Anna Minarini, et al.
Amino Acids|August 23, 2011
Synthetic polyamines as potential amine oxidase inhibitors: a preliminary studyBonaiuto Emanuela, Anna Minarini, Vincenzo Tumiatti, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2018
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitorsAndrea Milelli, Chiara Marchetti, Eleonora Turrini, et al.
Farmaco (Societa Chimica Italiana : 1989)|May 10, 2005
Heterocyclic inhibitors of AChE acylation and peripheral sitesMaria Laura Bolognesi, Vincenza Andrisano, Manuela Bartolini, et al.
Bioorganic & Medicinal Chemistry|July 4, 2008
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinicsAnna Minarini, Gabriella Marucci, Cristina Bellucci, et al.
ACS Chemical Neuroscience|April 20, 2017
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational ApproachElena Simoni, Melania M Serafini, Roberta Caporaso, et al.
Scientific Reports|September 10, 2016
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer's DiseaseAngelo M Reggiani, Elena Simoni, Roberta Caporaso, et al.
Journal of Medicinal Chemistry|October 31, 2003
Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptorsMichela Rosini, Alessandra Antonello, Andrea Cavalli, et al.
Molecules (Basel, Switzerland)|November 14, 2023
Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected TargetsFilippo Basagni, Maria Luisa Di Paolo, Giorgio Cozza, et al.
Pageof 8